Skip to search formSkip to main contentSkip to account menu

ST2 gene

Known as: ST2, Suppression of Tumorigenicity 2 Gene, suppression of tumorigenicity 2 
Human ST2 gene is located within 11p14.3-p12 and has no known gene product. This locus may play a role in tumor suppression.
National Institutes of Health

Related topics

Related topics

4 relations
Cell Proliferation Regulatory ProcessHomo sapiensNeoplastic Cell TransformationTumor Suppression

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Serum ST2 and hospitalization rates in Caucasian and African American outpatients with heart failure.
2019
2019
IL-33 promotes the progression of nonrheumatic aortic valve stenosis via inducing differential phenotypic transition in valvular interstitial cells.
2019
2019
Could interleukin-33 and its suppressor of tumorigenicity 2 (ST2) receptor have a role in cervical human papillomavirus (HPV) infections?
Abstract Why most women can clear human papillomavirus (HPV) infections while others can develop permanent infections. The… 
2019
2019
Prognostic value of ST2 in myocardial infarction.
INTRODUCTION Soluble Suppression of Tumorigenicity 2 (ST2) is a biomarker of myocardial fibrosis increasingly recognized as a… 
2018
2018
Increased serum levels of IL‐33 and soluble ST2 in neonates with human cytomegalovirus infection
Interleukin 33 (IL‐33) and soluble form of ST2 (sST2) are involved in inflammation. This study aimed to assess the role of serum… 
2016
2016
Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1.
2014
2014
Interleukin-33 promotes disease progression in patients with primary biliary cirrhosis.
Primary biliary cirrhosis (PBC) is a progressive autoimmune liver disease that can cause a series of complications, including… 
2014
2014
Hemorrhage-induced interleukin-1 receptor pathway in lung is suppressed by 3,5-bis(2-fluorobenzylidene)-4-piperidone in a rat model of hypovolemic shock.
Severe blood loss in victims of trauma creates an exaggerated inflammatory background that contributes to the development of… 
2013
2013
Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
BACKGROUND Two fibrosis biomarkers, galectin-3 (Gal-3) and suppression of tumorigenicity 2 (ST2), provide prognostic value… 
2011
2011
Loss of suppression of tumorigenicity 2 (ST2) gene reverses sepsis-induced inhibition of lung host defense in mice.
RATIONALE After surviving the initial hyperinflammatory phase, patients with sepsis display features consistent with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)